Current use of dietary supplementation in patients with age-related macular degeneration

Canadian Journal of Ophthalmology

Volumn 38, Issue 1, 2003, Pages 27-32

  Chang, Charmaine W ^a   Chu, Gabriel ^a   Hinz, Brad J ^a   Greve, Mark D J ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE   (Canada)

Author keywords

Antioxidant; Dietary supplement; Macular degeneration; Zinc

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CENTRUM; ICAPS TR; MULTIVITAMIN; OCUVITE; VITALUX; ZINC;

ADULT; AGED; ARTICLE; CANADA; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DISEASE COURSE; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; RETINA MACULA AGE RELATED DEGENERATION; SMOKING;

EID: 0037295678     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(03)80005-4     Document Type: Article

References (5)

1. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Ophthalmol 2001;119:1417-36.
2. Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington: National Academy Press; 2000. p. 35-57, 366-71, 393-400.
3. Vitamin supplements [labelling standard]. Ottawa: Drugs Directorate, Health Protection Branch; 1995. Available: www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/guides/label/drug /vitsupls_e.pdf
4. Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington: National Academy Press; 2001. p. 193-5, 322-4, 379-81.
5. Mineral supplements [labelling standard]. Ottawa: Drugs Directorate, Health Protection Branch; 1996.Available:www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/guides/label /drug/minsupls_e.pdf